Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Illmer

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemiaMartin Bornhäuser, Thomas Illmer, Uta Oelschlaegel, et al.
Current Clinical Pharmacology|September 11, 2008
Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patientsStefan Pursche, Eberhard Schleyer, Malte von Bonin, et al.
British Journal of Haematology|January 5, 2008
Identification of acute myeloid leukaemia associated microRNA expression patternsFabienne Isken, Björn Steffen, Sylvia Merk, et al.
Haematologica|June 7, 2007
Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia IntergroupMarkus Schaich, Richard F Schlenk, Haifa K Al-Ali, et al.
BMC Cancer|December 12, 2025
Uncovering gaps in personalised lung cancer care in Germany: a white spot analysisScarlett Berressem, Lars-Thorben Moos, Johanna Röder, et al.
Experimental Hematology|July 26, 2011
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemiaDmitriy Ovcharenko, Friedrich Stölzel, David Poitz, et al.
Biochimica Et Biophysica Acta|October 19, 2013
MiR-134-mediated β1 integrin expression and function in mesenchymal stem cellsDavid M Poitz, Friedrich Stölzel, Laleh Arabanian, et al.
Haematologica|December 22, 2018
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progressionJohn F Seymour, Robert Marcus, Andrew Davies, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2019
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN)Annamaria Brioli, Kirsi Manz, Markus Pfirrmann, et al.
Haematologica|March 4, 2014
MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cellsLaleh S Arabanian, Fernando A Fierro, Friedrich Stölzel, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemiaMartin Bornhäuser, Thomas Illmer, Uta Oelschlaegel, et al.
Current Clinical Pharmacology|September 11, 2008
Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patientsStefan Pursche, Eberhard Schleyer, Malte von Bonin, et al.
British Journal of Haematology|January 5, 2008
Identification of acute myeloid leukaemia associated microRNA expression patternsFabienne Isken, Björn Steffen, Sylvia Merk, et al.
Haematologica|June 7, 2007
Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia IntergroupMarkus Schaich, Richard F Schlenk, Haifa K Al-Ali, et al.
BMC Cancer|December 12, 2025
Uncovering gaps in personalised lung cancer care in Germany: a white spot analysisScarlett Berressem, Lars-Thorben Moos, Johanna Röder, et al.
Experimental Hematology|July 26, 2011
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemiaDmitriy Ovcharenko, Friedrich Stölzel, David Poitz, et al.
Biochimica Et Biophysica Acta|October 19, 2013
MiR-134-mediated β1 integrin expression and function in mesenchymal stem cellsDavid M Poitz, Friedrich Stölzel, Laleh Arabanian, et al.
Haematologica|December 22, 2018
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progressionJohn F Seymour, Robert Marcus, Andrew Davies, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2019
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN)Annamaria Brioli, Kirsi Manz, Markus Pfirrmann, et al.
Haematologica|March 4, 2014
MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cellsLaleh S Arabanian, Fernando A Fierro, Friedrich Stölzel, et al.
Pageof 8